-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Defining efficacy in meningococcal vaccine trials
Paul B Keiser, Christopher J Gill
Review: Clinical Trail Outcomes: Clinical Investigation
-
Defining efficacy in meningococcal vaccine trials
Paul B Keiser, Christopher J Gill
Review: Clinical Trail Outcomes: Clinical Investigation
-
Defining efficacy in meningococcal vaccine trials
Paul B Keiser, Christopher J Gill
Review: Clinical Trail Outcomes: Clinical Investigation
-
Defining efficacy in meningococcal vaccine trials
Paul B Keiser, Christopher J Gill
Review: Clinical Trail Outcomes: Clinical Investigation
-
Defining efficacy in meningococcal vaccine trials
Paul B Keiser, Christopher J Gill
Review: Clinical Trail Outcomes: Clinical Investigation
-
Defining efficacy in meningococcal vaccine trials
Paul B Keiser, Christopher J Gill
Review: Clinical Trail Outcomes: Clinical Investigation
-
Defining efficacy in meningococcal vaccine trials
Paul B Keiser, Christopher J Gill
Review: Clinical Trail Outcomes: Clinical Investigation
-
Defining efficacy in meningococcal vaccine trials
Paul B Keiser, Christopher J Gill
Review: Clinical Trail Outcomes: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation